Cargando…
SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use
Administration of an sodium–glucose cotransporter 2 inhibitor to individuals with insulin resistance reduces the level of glucose disposal necessary to maintain glycemia as a result of the induced increase in urinary glucose excretion. The amount of insulin required for a certain level of glucose di...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610101/ https://www.ncbi.nlm.nih.gov/pubmed/32469141 http://dx.doi.org/10.1111/jdi.13309 |